Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17521298rdf:typepubmed:Citationlld:pubmed
pubmed-article:17521298lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C1704242lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C0005330lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C0232539lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C0524828lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17521298lifeskim:mentionsumls-concept:C1418776lld:lifeskim
pubmed-article:17521298pubmed:issue3lld:pubmed
pubmed-article:17521298pubmed:dateCreated2007-5-24lld:pubmed
pubmed-article:17521298pubmed:abstractTextThe effect of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) on gastric secretion and gastric cytoprotection was evaluated using five different models of gastric ulcers: acetic acid-induced chronic gastric ulcers, pylorus ligation, ethanol-induced, indomethacin-induced and ischemia-reperfusion-induced gastric ulcers. Bezafibrate, a PPAR-alpha agonist was administered at two different doses of 10 and 100 mg/kg body weight intraperitoneanally. Both doses of bezafibrate showed significant antiulcer effect in ethanol-induced, indomethacin-induced and pylorus ligation-induced gastric ulcers. Bezafibrate increased healing of ulcer in acetic acid-induced chronic gastric ulcer model. Both doses were also effective in preventing gastric lesions induced by ischemia-reperfusion. It was concluded that PPAR-alpha activation increases healing of gastric ulcers and also prevents development of gastric ulcers in rats.lld:pubmed
pubmed-article:17521298pubmed:languageenglld:pubmed
pubmed-article:17521298pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:citationSubsetIMlld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17521298pubmed:statusMEDLINElld:pubmed
pubmed-article:17521298pubmed:monthJunlld:pubmed
pubmed-article:17521298pubmed:issn0767-3981lld:pubmed
pubmed-article:17521298pubmed:authorpubmed-author:AsadMohammedMlld:pubmed
pubmed-article:17521298pubmed:authorpubmed-author:PathakRahulRlld:pubmed
pubmed-article:17521298pubmed:authorpubmed-author:Hrishikeshava...lld:pubmed
pubmed-article:17521298pubmed:authorpubmed-author:PrasadSatyaSlld:pubmed
pubmed-article:17521298pubmed:issnTypePrintlld:pubmed
pubmed-article:17521298pubmed:volume21lld:pubmed
pubmed-article:17521298pubmed:ownerNLMlld:pubmed
pubmed-article:17521298pubmed:authorsCompleteYlld:pubmed
pubmed-article:17521298pubmed:pagination291-6lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:meshHeadingpubmed-meshheading:17521298...lld:pubmed
pubmed-article:17521298pubmed:year2007lld:pubmed
pubmed-article:17521298pubmed:articleTitleEffect of peroxisome proliferator-activated receptor-alpha agonist (bezafibrate) on gastric secretion and gastric cytoprotection in rats.lld:pubmed
pubmed-article:17521298pubmed:affiliationDepartment of Pharmacology, Krupanidhi College of Pharmacy, #5 Sarjapur Road, Koramangala, Bangalore 560 034, India.lld:pubmed
pubmed-article:17521298pubmed:publicationTypeJournal Articlelld:pubmed